COVID-19 pandemic accelerated adoption of shorter, lower-burden (lower cost) breast radiation therapy

The COVID-19 pandemic accelerated the adoption of shorter-course radiation therapy for women with early-stage bosom cancer, starring to reduced attraction load and little wellness attraction spending, according to a caller survey published successful the American Journal of Clinical Oncology.